|Day Low/High||322.16 / 329.71|
|52 Wk Low/High||184.43 / 339.94|
Chances are that global monetary policy tightens considerably this week and that the U.S. will not be the primary driver.
The Delta virus has more power to control both fiscal and monetary policy than does the data or do any of our leaders individually.
The fund is at a key spot technically, and there is real fear that if this spot cracks, what looks like a stretch of rough rapids could become a waterfall.
Cryptos and cash are both headed for a real fight. For their own existence.
The fact is that even if there is some compromise, the next fiscal stimulus package will be closer to $1.9 trillion than $600 billion.
As power has changed hands in the White House, we can expect these names -- and themes -- to benefit.
Top investment ideas from seven of CFRA Research's equity analysts.
We have to take both the private sector and the states out of the equation, and adopt the process that wiped out Polio.
The shares have been digesting and consolidating the gains achieved in early November.
The stock hasn't done much of late, but perhaps FedEx's earnings report Thursday will offer clues of what's going on in delivery.
Vaccines are on the move (a big plus) even as members of Congress continue to dawdle on a fiscal support package (a big minus).
Most important come Inauguration Day is the seamless transition of leadership over 'Operation Warp Speed'.
The battle to gain control over Covid-19 is entering a crucial stage and calls for continued determination.
All in all stick with the tipping pointers, they are the drivers of this and the next leg higher.
I will come back to these names over and over again as we are now in the sweet spot for many.
None of these questions have been answered which is why I see chaos ahead as we can't even imagine this process working.
Basically, I think we laid out enough reasons for financial markets to revolt, yet they did not.
Here's to the removal of uncertainty -- and thousands of campaign signs on thousands of lawns in my neighborhood.
With 33 years of consecutive dividend increases, this health care name is a member of the Dividend Aristocrats Index.
Several sessions over the past 10 days have seen increased trading volume at the NYSE, but not the Nasdaq, and for the S&P 500, but not the Nasdaq Composite. Is this professional risk reduction?
Plus, there's talk of a possible combination of Advanced Micro Devices and Xilinx.
Plus, reading tea leaves in the recent action in Apple and Salesforce.com.
But that's exactly where we are right now, in this third day of the rotation, so here's your path to safety.
Plus, Russia could provide a real-time clinical trial of a coronavirus vaccine.